BEIJING, April 30, 2025 /PRNewswire/ — Gaotu Techedu Inc. (“Gaotu” or the “Company”) (NYSE: GOTU), a technology-driven education company and online large-class tutoring service provider in China, today announced that it will report its financial results for the first quarter ended March 31, 2025, before U.S. markets open on Thursday, May 15, 2025.
Gaotu’s management will hold an earnings conference call at 8:00 AM U.S. Eastern Time on Thursday, May 15, 2025 (8:00 PM on the same day, Beijing/Hong Kong Time). Dial-in details for the earnings conference call are as follows:
|
International: |
+1-412-317-6061 |
|
United States: |
+1-888-317-6003 |
|
Hong Kong: |
800-963-976 |
|
Mainland China: |
400-120-6115 |
|
Passcode: |
7885398 |
A telephone replay will be available two hours after the conclusion of the conference call through May 22, 2025. The dial-in details are as follows:
|
International: |
+1-412-317-0088 |
|
United States: |
+1-877-344-7529 |
|
Passcode: |
5203831 |
Additionally, a live and archived webcast of this conference call will be available at https://ir.gaotu.cn/home.
About Gaotu Techedu Inc.
Gaotu is a technology-driven education company and online large-class tutoring service provider in China. The Company offers learning services and educational content & digitalized learning products. Gaotu adopts an online live large-class format to deliver its courses, which the Company believes is the most effective and scalable model to disseminate scarce high-quality teaching resources to aspiring students in China. Big data analytics permeates every aspect of the Company’s business and facilitates the application of the latest technology to improve teaching delivery, student learning experience, and operational efficiency.
For further information, please contact:
Gaotu Techedu Inc.
Investor Relations
E-mail: [email protected]
Piacente Financial Communications
Brandi Piacente
Tel: +1 212 481-2050
Jenny Cai
Tel: +86 10 6508-0677
Email: [email protected]
ข่าวที่เกี่ยวข้อง
- Accro Bioscience Announces First Patient Enrolled in Phase II/III Clinical Trial of Highly Selective TYK2/JAK1 Inhibitor AC-201 for Non-Segmental Vitiligo
- From Property Development to Industry Leadership: Tan Lindy’s Vision for BCB Berhad
- เปิดตัว ATMA: มิติใหม่แห่งการดูแลสุขภาวะโดย Aman Group
- Hoymiles CEO Yang Bo Named to TIME100 Climate 2026, Following HiFlow Pro’s Recognition as a TIME Best Invention
